Biosimilars Survey 2019

The GI Society recently launched a survey on patient opinions and outlook regarding biologic medications, including biosimilars.

They’re inviting Canadian patients, from all disease areas, treated with biologic medications. They will use the information gathered anonymously and in aggregate to shape future programming and to inform community members, healthcare professionals, and health policy decision-makers.

Here is the link to the survey: